IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The study objective is the eluciation of the dose-response function in efficacy (and possibly
safety) in order to determine an optimal dose with respect to efficacy and safety. The study
is designed with three dose levels and one placebo control.